Skip to content

Author

Markus Barden

We have 2 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

CAR T cell cancer immunotherapy: who does the job?

This review reframe CAR T cell therapy as the induction of a multi-system immune response rather than a uni-directional cytotoxic cell-autonomous intervention, and proposes that a calibrated, broad immune cell activation should be viewed as design principle for next-generation CAR T cell therapies.

D. Harrer, Markus Barden, H. Abken · 0 citations
Review Open access Aug 2026

In vivo CAR T cells on the highway: a roadmap for the next decade

Although still in its infancy, in vivo genetic engineering shows promise for CAR T cell therapy in a wide range of cancer patients and has the potential to reprogram patients’ immunity in autoimmunity, chronic infections, and regenerative medicine.

Markus Barden, D. Harrer, Hinrich Abken · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.